Acute cytomegalovirus infection complicated by venous thrombosis: a case report by Rovery, Clarisse et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Annals of Clinical Microbiology and 
Antimicrobials
Open Access Case report
Acute cytomegalovirus infection complicated by venous 
thrombosis: a case report
Clarisse Rovery1,2, Brigitte Granel3, Philippe Parola2, Cédric Foucault1,2 and 
Philippe Brouqui*1,2
Address: 1Unité des Rickettsies, UMR6020, Faculté de Médecine, Université de la Méditerranée, Marseille, France, 2Service de Maladies infectieuses 
et de Médecine tropicale, Hôpital Nord, Chemin des Bourrelys, 13915 Marseille Cedex 20, France and 3Service de Médecine Interne, Hôpital Nord, 
Chemin des Bourrelys, 13915 Marseille Cedex 20, France
Email: Clarisse Rovery - crovery@hotmail.com; Brigitte Granel - brigitte.granel@ap-hm.fr; Philippe Parola - philippe.parola@medecine.univ-
mrs.fr; Cédric Foucault - cedric.foucault@medecine.univ-mrs.fr; Philippe Brouqui* - philippe.brouqui@medecine.univ-mrs.fr
* Corresponding author    
Abstract
Background: CMV-induced vasculopathy and thrombosis have been reported, but they are rare
conditions usually encountered in immunocompromised patients. However more and more
complications of CMV infections are recognized in immunocompetent patients.
Case presentation: We present a case report of a previously healthy adult with cytomegalovirus
infection that was complicated by tibiopopliteal deep venous thrombosis and in whom Factor V
Leiden heterozygous mutation was found.
Conclusion: This new case report emphasizes the involvement of cytomegalovirus in induction of
vascular thrombosis in patients with predisposing risk factors for thrombosis. It is necessary to
screen for CMV infection in patients with spontaneous thrombosis and an history of fever.
Backgound
CMV-induced vasculopathy and thrombosis have been
reported, but they are rare conditions. The few published
reports on these conditions focus either on immunocom-
promised transplant recipients who are receiving high-
dose immunosuppressive agents [1,2] or on HIV-infected
patients [3-5]. We report one new case of acute CMV infec-
tion in a non-immunocompromised adult that presented
as spontaneous venous thrombosis. There are few reports
involving immunocompetent adults, and these reports
are additional arguments for the implication of CMV in
vasculopathy and thrombosis.
Case presentation
A 33-year-old white man with a 5-day history of fever, was
hospitalized on May 2004. He also reported epigastralgia
and pain in the right leg. He had an history of femoral
deep venous thrombosis ten years before. His mother and
his brother had an history of deep venous thrombosis and
his father died because of pulmonary embolism. Physical
examination revealed fever (temperature range 38°C–
38°5C), asthenia, headache, anorexia and epigastralgia.
His right leg was enlarged and painful. Tibiopopliteal
deep venous thrombosis was confirmed by Doppler ultra-
sonography. At the time of hospital admission, his WBC
was 6,000 cells/mm3, with 2,100 neutrophils/mm3 and
2,820 lymphocytes/mm3, with 9% of hyperbasophilic
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lymphocytes. His platelet count was 120,000/mm3 and
his hemoglobin level was 141 g/l. The C-reactive protein
level was 52 mg/l. Liver function tests revealed an ALT
level of 65 UI/l, an AST level of 64 UI/l, an LDH level of
891 UI/l, a PAL level of 61 UI/l and a γ-GT level of 41 UI/
l. Blood cultures were sterile. The results of serological
tests for HIV ELISA, hepatitis A IgM, hepatitis B surface
antigen, hepatitis C virus, Q fever, and toxoplasma were
negative. VCA and EBNA IgG antibodies were positive
suggesting past immunization. Serological test for CMV
ELISA was strongly positive for IgM antibodies. The result
of a CMV pp65 antigenemia assay, based on the direct
detection of the CMV pp65 phosphoprotein was positive.
A second serological test for CMV taken two weeks after
the first one showed seroconversion with appearance of
IgG. No pathological values for prothrombin time ratio,
activated partial thromboplastin time, plasma anti-
thrombin III, protein C and S activity were found. Results
of tests for anticardiolipin antibodies, lupus anticoagulant
and prothrombin 20210 were negative. Antinuclear anti-
bodies were negative and complement was normal. Factor
V Leiden heterozygous mutation was found. Anticoagu-
lant treatment was introduced. Tthe patient became
asymptomatic and was discharged from the hospital.
Discussion
Our observation, as well those of others [6,7], argues for
implication of CMV in vasculopathy and thrombosis. In
these cases, thrombosis occurred in immunocompetent
patients during CMV infection, which was confirmed, in
most cases, by pp65 antigen and/or CMV viremia/viruria.
There are few reports involving immunocompetent adults
since we retrieved only 13 reports through MEDLINE
database [6-16]. Predisposing risk factors for thrombosis
have sometimes been found in the reported cases such as
protein C and S deficiency [15] and the presence of
antiphospholipid antibodies [10,13,16,17]. In other
reports, patients were women and had risk factors such as
oral contraceptive use [8,9,14]. The factor V Leiden heter-
ozygous mutation was only reported once previously [6].
However in some other reported cases, no hemostatic
abnormalities can be found [6,7,17] and spontaneous res-
olutions of thrombosis were observed in some of these
patients who did not receive anticoagulant treatment [9].
This suggests that CMV was the sole triggering factor.
These observations suggest that acute CMV infection may
be the cause of the thrombosis event in these patients.
However, it is difficult to determine whether CMV is a
direct cause of thrombosis or a precipitating factor in
patients with underlying thrombogenic tendency. Con-
sidering that CMV could be a transient triggering factor for
thrombosis in our patient, we decided not to treat lifelong
as recommended for patients with factor V Leiden hetero-
zygous mutation and 2 spontaneous thrombosis [18] but
only for 6 months [19].
In conclusion, our case report reinforces the opinion that
CMV is a rare but potentially signifiant cause or precipitat-
ing factor of arterial and venous thrombosis in immuno-
competent hosts [20]. It seems to be necessary to screen
for CMV infection in patients with spontaneous thrombo-
sis and an history of fever. It is important to recognize
CMV infection in these patient as it may be possible to
consider the discontinuation of anticoagulant therapy
earlier.
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